What does Lotte Healthcare and Biopharmaceutical CVC invest in?

Lotte Healthcare and Biopharmaceutical CVC invests in Biotech, Drug Discovery, Diagnostics and Medtech at the pre-seed, seed and series-a stages.

Which geographies does Lotte Healthcare and Biopharmaceutical CVC focus on?

Lotte Healthcare and Biopharmaceutical CVC focuses on United States, Japan, Taiwan, Switzerland and South Korea, and is headquartered in Japan.

Open Lotte Healthcare and Biopharmaceutical CVC in the live Raise dashboard →

Explore: Biotech · Drug Discovery · Diagnostics · Medtech · Pre-Seed · Seed · Series A

Lotte Healthcare and Biopharmaceutical CVC

Lotte Holdings

Corporate VCCo-invests

Location

🇯🇵Japan

Links

Website

Investment Thesis

Investment in Korean and global biotechnology companies, with focus on antibodies and antibody-drug conjugates (ADCs). First vehicle established August 2024 with ~10 investments across US, Japan, Taiwan, and Switzerland; second fund expected to close within a year with Korea as a new primary focus.

About Lotte Healthcare and Biopharmaceutical CVC

LOTTE Holdings launched a healthcare and biopharmaceutical CVC to invest in biopharmaceuticals and next-generation modalities, with a stated goal of gathering cutting-edge insights and accelerating access to innovative technologies. It targets startups globally and across all stages.

Sectors

BiotechDrug DiscoveryDiagnosticsMedtech

Stages

pre-seedseedSeries A

Geographic focus

United StatesJapanTaiwanSwitzerlandSouth Korea

Notable Investments

Physiologas Technologies

Verified 5 June 2026 · Sources: company website, Fusion42 review

Frequently asked questions

What does Lotte Healthcare and Biopharmaceutical CVC invest in?: Lotte Healthcare and Biopharmaceutical CVC invests in Biotech, Drug Discovery, Diagnostics and Medtech at the pre-seed, seed and series-a stages.
Which geographies does Lotte Healthcare and Biopharmaceutical CVC focus on?: Lotte Healthcare and Biopharmaceutical CVC focuses on United States, Japan, Taiwan, Switzerland and South Korea, and is headquartered in Japan.